Microbiome Connect - Skin - EU 2020 | Kisaco Research

Translating ground-breaking skin microbiome research into commercial, personal-care applications.

View Agenda
Virtual
10-11 November, 2020

“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!”

Mike Conti, Solabia

Why Attend

2019 proved to be a pivotal year for the skin microbiome, as personal care giants Unilever launched their Dove range of ‘microbiome-friendly’ skincare products. Clearly, the biggest players in beauty and personal care have recognised the potential commercial value of skin microbiome-based consumer product claims and formulations.

Moving forward into 2021, the market will continue to see more and more products launched with microbiome claims backed through next-generation sequencing techniques. Including ingestible beauty products that influence the gut-skin axis, to truly personalized skincare solutions and mass market formulations – there’s a huge commercial opportunity to commercialise skin microbiome research into consumer care products. 

So, what’s different at Microbiome Connect: Skin EU Virtual?

Six new topics to explore:

  • The skin-gut axis and the development of ingestible beauty products.
  • Personalisation of skin-microbiome products and formulation considerations.
  • Defining skin-microbiome industry terminology and developing scientifically backed claims that resonate with consumers.
  • Next generation sequencing techniques and their application in claims development.
  • New data demonstrating the role of the microbiome in common skin conditions including acne, eczema and dandruff.
  • The vaginal and oral microbiomes and the mass market product development opportunities to treat gingivitis/periodontitis and sexually transmitted infections.

Industry leading Speakers

 

Mike Hoptroff

Senior R&D Manager
Unilever

Michael Hoptroff is a senior R&D manager at Unilever with over 21 years experience in advancing the science of skin microbiology and the skin microbiome and the development of personal care products. In this time he has worked within Unilever and with a range of industrial and academic partners on projects ranging from handwashing to scalp care to body as well as being active in oral microbiology research.

Mike Hoptroff

Senior R&D Manager
Unilever

Mike Hoptroff

Senior R&D Manager
Unilever

Michael Hoptroff is a senior R&D manager at Unilever with over 21 years experience in advancing the science of skin microbiology and the skin microbiome and the development of personal care products. In this time he has worked within Unilever and with a range of industrial and academic partners on projects ranging from handwashing to scalp care to body as well as being active in oral microbiology research.

 

Audrey Gueniche Ph.D

Senior Clinical Expert
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials.

Audrey Gueniche Ph.D

Senior Clinical Expert
L'Oréal

Audrey Gueniche Ph.D

Senior Clinical Expert
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials. Her passion is to always reinvent evaluation and find new fields of area in term of actives to promote. 

She has published over 110 papers in peer-reviewed journals, 5 chapters in books, 2 specials issues in journal where she was the invited editor. She presented in over 80 international congresses and additionally she was personally invited to give more than 35 keynote lectures.

 

Geoff Briggs

Technology Scout (Devices & Diagnostics)
Walgreens Boots Alliance – Global R&D

Geoff Briggs

Technology Scout (Devices & Diagnostics)
Walgreens Boots Alliance – Global R&D

Geoff Briggs

Technology Scout (Devices & Diagnostics)
Walgreens Boots Alliance – Global R&D
 

Kimberly Capone

Head, Microbiome Platform
Johnson & Johnson

Kimberly Capone is a Research Fellow and Lead Microbiologist for Skin Microbiome Research with Johnson & Johnson Consumer Companies, Inc. in Skillman, NJ. She received her B.S. in Biology from Northeastern University in Boston, MA, proceeding to earn her Ph.D. in Microbiology and Immunology from Northwestern University in Chicago, IL. As a Research Fellow at Johnson & Johnson Consumer Companies, Inc., Dr. Capone directs investigations into the human skin microbiome in health and disease, particularly early in life and in individuals with sensitive or inflamed skin.

Kimberly Capone

Head, Microbiome Platform
Johnson & Johnson

Kimberly Capone

Head, Microbiome Platform
Johnson & Johnson

Kimberly Capone is a Research Fellow and Lead Microbiologist for Skin Microbiome Research with Johnson & Johnson Consumer Companies, Inc. in Skillman, NJ. She received her B.S. in Biology from Northeastern University in Boston, MA, proceeding to earn her Ph.D. in Microbiology and Immunology from Northwestern University in Chicago, IL. As a Research Fellow at Johnson & Johnson Consumer Companies, Inc., Dr. Capone directs investigations into the human skin microbiome in health and disease, particularly early in life and in individuals with sensitive or inflamed skin. In the course of her work, Dr. Capone has authored numerous peer-reviewed papers and has participated in national and international dermatology conferences. 

 

Sarah Lebeer

Professor
University of Antwerp

Sarah Lebeer

Professor
University of Antwerp

Sarah Lebeer

Professor
University of Antwerp
 

Sarah De Szalay

Global Category R&D Manger
Reckitt Benckiser

Sarah De Szalay

Global Category R&D Manger
Reckitt Benckiser

Sarah De Szalay

Global Category R&D Manger
Reckitt Benckiser
 

Dr. Jay Tiesman

Genomics Group Lead
Procter & Gamble

Dr. Jay Tiesman is a Principal Scientist in the Global Biotechnology Division of The Procter & Gamble Company in Cincinnati, Ohio, USA. He is the Genomics Group Leader and a Corporate Technology Entrepreneur – charged with helping to identify novel biotechnology innovations worldwide to address key needs for P&G. Since joining P&G in 1993, he has been actively involved in developing genomics capabilities within the Company. He has been particularly interested in the use of genomics to gain insight into epithelial cell biology.

Dr. Jay Tiesman

Genomics Group Lead
Procter & Gamble

Dr. Jay Tiesman

Genomics Group Lead
Procter & Gamble

Dr. Jay Tiesman is a Principal Scientist in the Global Biotechnology Division of The Procter & Gamble Company in Cincinnati, Ohio, USA. He is the Genomics Group Leader and a Corporate Technology Entrepreneur – charged with helping to identify novel biotechnology innovations worldwide to address key needs for P&G. Since joining P&G in 1993, he has been actively involved in developing genomics capabilities within the Company. He has been particularly interested in the use of genomics to gain insight into epithelial cell biology.

Before joining P&G, he completed postdoctoral training in the laboratory of Dr. Charlie Hart at ZymoGenetics, Inc. in Seattle, Washington. At ZymoGenetics, he pursued research in the field of growth factor signal transduction associated with wound healing and tissue remodeling. 

He obtained his Ph.D. in Pathology from the University of Nebraska Medical Center in Omaha, Nebraska. In Omaha, he worked in the Laboratory of Dr. Angie Rizzino at the Eppley Cancer Institute, delineating the roles and impact of growth factors on embryonic development.

Before joining Dr. Rizzino, he obtained Bachelor degrees in Philosophy and Biology at Creighton University in Omaha. Dr. Tiesman was an early adopter of microarray technology, having worked in the field since 1997. He is an acknowledged microarray expert and has published over 35 articles, two of which have earned “Publication of the Year” honors.

He also speaks extensively at international meetings on the topic of microarray experimental design and is listed on over 85 presentations. He collaborates extensively with scientists in academia and the biotechnology industry and is a member of several academic/governmental/industrial organizations, including the Association of Biomedical Resource Facilities Microarray Research Group (ABRF-MARG), the Association of Molecular Pathology (AMP), and the Society for Investigative Dermatology (SID); as well as the Scientific Advisory Board of NuGEN Technologies, Inc.

 

Stephanie Tang

External Innovation, Dermatology
Bayer

Stephanie Tang

External Innovation, Dermatology
Bayer

Stephanie Tang

External Innovation, Dermatology
Bayer
 

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

His research interests are in pediatric emergency medicine and health policy and to improve pediatric acute care across the United States. 

 

Paolo Perguia

Professor
University of Pavia

Paolo Perguia

Professor
University of Pavia

Paolo Perguia

Professor
University of Pavia
 

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard completed his PhD in synthetic biology, working together in collaboration with the pharmaceutical industry to engineer bacteria as a living pill. He is a scientific co-founder of S-Biomedic, and is leading the research and product development. 

His passion is understanding the complex interplay of the bacterial communities that live within and on us. He is fascinated by the untouched potential of active compounds that are naturally produced everyday right on our own skin.

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard completed his PhD in synthetic biology, working together in collaboration with the pharmaceutical industry to engineer bacteria as a living pill. He is a scientific co-founder of S-Biomedic, and is leading the research and product development. 

His passion is understanding the complex interplay of the bacterial communities that live within and on us. He is fascinated by the untouched potential of active compounds that are naturally produced everyday right on our own skin.

 

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

 

Marie Drago

Founder
Gallinée

Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin?

Marie Drago

Founder
Gallinée

Marie Drago

Founder
Gallinée

Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin?

Marie’s thesis on the microbiome and the enormous benefits of harnessing helpful bacteria gave her the vision and the know-how to create Gallinée’s formulations. Thanks to her pharmacy background and her beauty experience, Marie designed formulas like no other, and patented the triple biotic complex that you can now find in Gallinée’s products.

 

Dr Cath O'Neill

Chief Scientific Officer
SkinBioTherapeutics

Dr Cath O'Neill

Chief Scientific Officer
SkinBioTherapeutics

Dr Cath O'Neill

Chief Scientific Officer
SkinBioTherapeutics
 

Elsa Jungman

Founder
ELSI Skin Health

Dr. Elsa Jungman has a Ph.D. in Skin Delivery and began her career working in Research and Development for L’Oreal in Paris. In 2015 she moved to San Francisco and has worked with several biotech and skincare companies such as AOBiome. She is an expert for the Clean Beauty Council at Credo Beauty and mentors/consults with local small companies. Today, she is the founder and CEO of ELSI Skin Health, a science-backed and clean skincare startup.

Elsa Jungman

Founder
ELSI Skin Health

Elsa Jungman

Founder
ELSI Skin Health

Dr. Elsa Jungman has a Ph.D. in Skin Delivery and began her career working in Research and Development for L’Oreal in Paris. In 2015 she moved to San Francisco and has worked with several biotech and skincare companies such as AOBiome. She is an expert for the Clean Beauty Council at Credo Beauty and mentors/consults with local small companies. Today, she is the founder and CEO of ELSI Skin Health, a science-backed and clean skincare startup.

 

Assaf Oron

Chief Business Officer
Biomx

Assaf Oron

Chief Business Officer
Biomx

Assaf Oron

Chief Business Officer
Biomx
 

Emma Taylor

CEO & Co-Founder
Naked Biome

Dr. Emma Taylor the CEO and co-founder of Naked Biome, a microbiome therapeutics company, focused in acne She is a UCLA-trained and board certified Dermatologist and Dermatopathologist, and former assistant professor of Dermatology and Dermatopathology at UCLA, where she c0-founded Naked Biome. She is also an inventor of 2 published patents, has published in notable journals such as Nature and the Journal of the American Academy of Dermatology, and is the author on more than 40 book chapters.

Emma Taylor

CEO & Co-Founder
Naked Biome

Emma Taylor

CEO & Co-Founder
Naked Biome

Dr. Emma Taylor the CEO and co-founder of Naked Biome, a microbiome therapeutics company, focused in acne She is a UCLA-trained and board certified Dermatologist and Dermatopathologist, and former assistant professor of Dermatology and Dermatopathology at UCLA, where she c0-founded Naked Biome. She is also an inventor of 2 published patents, has published in notable journals such as Nature and the Journal of the American Academy of Dermatology, and is the author on more than 40 book chapters.

 

Thomas Dawson

Senior Principal Investigator
A* Agency for Science, Technology and Research

Thomas Dawson earned his PhD degree in pharmacology from the University of North Carolina in 1994 and was a Clinical Medical Genetics Fellow in Pediatrics at the Duke University Medical Center from 1994-1996. From 1998-2015 he worked in Procter & Gamble’s Beauty Technology Division, before joining the Institute of Medical Biology (IMB), A*STAR, to develop and lead translational programs in hair and scalp biology. Dawson moved to the Skin Research Institute of Singapore (SRIS), A*STAR, in 2018.

Thomas Dawson

Senior Principal Investigator
A* Agency for Science, Technology and Research

Thomas Dawson

Senior Principal Investigator
A* Agency for Science, Technology and Research

Thomas Dawson earned his PhD degree in pharmacology from the University of North Carolina in 1994 and was a Clinical Medical Genetics Fellow in Pediatrics at the Duke University Medical Center from 1994-1996. From 1998-2015 he worked in Procter & Gamble’s Beauty Technology Division, before joining the Institute of Medical Biology (IMB), A*STAR, to develop and lead translational programs in hair and scalp biology. Dawson moved to the Skin Research Institute of Singapore (SRIS), A*STAR, in 2018.

 

Rich Gallo

Professor of Dermatology
UCSD

Rich Gallo

Professor of Dermatology
UCSD

Rich Gallo

Professor of Dermatology
UCSD

The Virtual Experience

Top 10 benefits

- Tailor Your Agenda 

- More Audience Participation

- Improved Audience Visibility 

- On-Demand Content

- High Quality Speakers 

- More Networking Opportunities 

- Save Time & Money 

- Increased Content 

- More insights 

- Business Development Opportunities - Talk to our team to find out out more [email protected].

Platform Preview

Who will be there

Meet Industry Leading Experts in:

  • Independent Beauty Brands and Biotech Companies;
  • Academic Researchers and Dermatologists;
  • Multinational Beauty & Personal Care Brands and Multinational Pharmaceutical Companies;
  • Cosmetic Formulators, Strain Manufacturers, Ingredients Suppliers, Packaging Manufacturers and Sequencing companies; 
  • Regulatory Experts and Consumer Trend Analysts; and
  • Retailers and Distributors

Skin Microbiome Past Attendees

Agenda

Complete your details to view the Microbiome Connect: Skin EU Virtual Agenda for 2020.

Take a look at our highlights video from the inaugural congress: 

Skin Microbiome Congress | 30 - 31 May 2018

3rd Annual European Microbiome Congress: The Next Big Thing in Microbiome...Skin

Download Agenda

Thought Leadership Partner

Senior Event Partner

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Saturday, September 19, 2020 to Friday, October 23, 2020
Independent beauty brands/biotechs/academics
€399
Early bird rate - ends 23rd Oct
This pass will give you access to all live content, 1-2-1 meetings and on-demand content across the 4 day event.
You will also have the ability to book 1-2-1 meetings throughout the 2 weeks that the event is taking place.
To increase your brand presence, contact Mark Gavhure, [email protected]
Saturday, September 19, 2020 to Friday, October 23, 2020
Multinational Beauty/Pharma/Personal Care
€799
Early bird rate - ends 23rd Oct
This pass will give you access to all live content, 1-2-1 meetings and on-demand content across the 4 day event.
You will also have the ability to book 1-2-1 meetings throughout the 2 weeks that the event is taking place.
To increase your brand presence, contact Mark Gavhure, [email protected]
Friday, September 18, 2020 to Thursday, December 31, 2020
Pre-Event Programme
Free
ON-DEMAND | Microbiome Connect Leadership Session | The impact of a pandemic on the skin microbiome
16th October | Eagle Genomics Hosted Session
2nd November | Labskin Hosted Session
Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.